PRGO logo

Perrigo (PRGO) Company Overview

Profile

Full Name:

Perrigo Company plc

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Ireland

IPO:

December 17, 1991

Indexes:

Not included

Website:

http://www.perrigo.com

Description:

Perrigo Company plc (PRGO) is a global healthcare company that develops and manufactures over-the-counter (OTC) and prescription products. They focus on consumer health, offering a wide range of products, including pain relief, allergy treatments, and vitamins, aiming to improve everyday health for consumers worldwide.

Key Details

Price

$27.30

Market Cap

$3.73 B(Mid cap)

Last Dividend

$0.29

TTM Dividend Yield

4.10%

Annual Revenue

$4.37 B(-6.06% YoY)

Annual EPS

-$1.25(-1288.89% YoY)

PE Ratio

-

Annual ROE

-3.78%

Annual Debt To Equity

0.84

Beta

0.54

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Mar 7, 2025
Splits

Next split:

N/A

Recent split:

Aug 26, 1993

Analyst ratings

Recent major analysts updates

Jan 6, 25 Piper Sandler
Neutral
Sep 30, 24 Canaccord Genuity
Buy
Sep 23, 24 Jefferies
Hold
Jul 11, 24 Piper Sandler
Overweight
Jun 13, 24 Piper Sandler
Overweight
Apr 12, 24 Canaccord Genuity
Buy
Apr 8, 24 Piper Sandler
Overweight
Feb 28, 24 JP Morgan
Overweight
Nov 17, 23 Piper Sandler
Overweight
Aug 9, 23 JP Morgan
Overweight

Screeners with PRGO included

Growing Shares Outstanding
Mid cap stocks
Most recommended stocks
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
Companies with growing dividends
All stocks
High yield dividend stocks
NYSE Companies

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$27.30
PRGO price is $27.30

Price All-time High

$203.69
PRGO price is currently -86.60% below its historical high of $203.69

Price Analysts Target

$35.00
PRGO price is currently -22.00% lower than the consensus analysts' forecast

Price Today Change

-0.73%
PRGO price is down -0.73% today

Price YTD Change

+6.18%
PRGO price is up +6.18% since January 1st

Price 3-Year Change

-27.62%
PRGO price is down -27.62% over the past 3 years

Market cap

Market Cap

$3.73 B
PRGO market capitalization is $3.73 billion

Market Cap 3-Year Change

-26.59%
PRGO market capitalization is down -26.59% over the past 3 years

Market Cap All-time High

$29.03 B
PRGO market capitalization is currently -87.17% below its historical high of $29.03 billion

Market Cap Sector Rank

87.49%
PRGO market capitalization is higher than 87.49% of companies in Healthcare sector

Technical

Beta

0.54
PRGO beta is 0.54

200-day SMA

$26.57
PRGO price is currently +2.73% above its 200-day simple moving average

14-day RSI

59.84
PRGO 14-day relative strength index is 59.84

30-day Relative Volume

1.09
PRGO 30-day relative volume is 1.09

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.29
PRGO last dividend was $0.29 per share, with an ex-dividend date of March 7, 2025

Next Dividend

-
PRGO next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$1.10
PRGO annual dividend per share is $1.10

Annual Dividend Per Share Sector Rank

47.06%
PRGO annual dividend per share is higher than 47.06% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+1.1%
PRGO annual dividend per share is up +1.1% year-on-year

Annual Dividend Per Share 3-Year Change

+15%
PRGO annual dividend per share is up +15% over the past 3 years

Dividend yield

Annual Dividend Yield

4.04%
PRGO annual dividend yield is 4.04%

Annual Dividend Yield Sector Rank

82.14%
PRGO annual dividend yield is higher than 82.14% of companies in Healthcare sector

Other

Annual Payout Ratio

-88.77%
PRGO annual payout ratio is -88.77%

Annual Dividends Paid

$152.50 M
PRGO annual dividends paid is $152.50 million

Annual FCF

$244.60 M
PRGO annual free cash flow is $244.60 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$4.37 B
PRGO annual revenue is $4.37 billion

Annual Revenue Analysts Estimate

$4.44 B
PRGO annual revenue is currently -1.45% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-6.06%
PRGO annual revenue is down -6.06% year-on-year

Annual Revenue Sector Rank

91.28%
PRGO annual revenue is higher than 91.28% of companies in Healthcare sector

Profit

Annual Gross Profit

$1.54 B
PRGO annual gross profit is $1.54 billion

Annual Gross Margin

35.27%
PRGO annual gross profit margin is 35.27%

Annual Operating Profit

$311.90 M
PRGO annual operating income is $311.90 million

Annual Operating Margin

7.13%
PRGO annual operating profit margin is 7.13%

Annual Net Income

-$171.80 M
PRGO annual net profit is -$171.80 million

Annual Net Margin

-3.93%
PRGO annual net profit margin is -3.93%

EPS

Annual EPS

-$1.25
PRGO annual earnings per share is -$1.25

Annual EPS Analysts Estimate

$2.97
PRGO annual earnings per share is currently -142.10% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-1288.89%
PRGO annual earnings per share is down -1288.89% year-on-year

Annual EPS Sector Rank

54.07%
PRGO annual earnings per share is higher than 54.07% of companies in Healthcare sector

ROA & ROE

Annual ROA

-1.68%
PRGO annual return on assets is -1.68%

Annual ROE

-3.78%
PRGO annual return on equity is -3.78%

EBIT & EBITDA

Annual EBIT

$107.10 M
PRGO annual earnings before interest & taxes is $107.10 million

Annual EBITDA

$433.00 M
PRGO annual EBITDA is $433.00 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
PRGO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
PRGO price to earnings ratio is unknown

PB Ratio

PB Ratio

0.86
PRGO price to book ratio is 0.86

PB Ratio Sector Rank

38.14%
PRGO price to book ratio is higher than 38.14% of companies in Healthcare sector

PS Ratio

PS Ratio

0.85
PRGO price to sales ratio is 0.85

PS Ratio Sector Rank

22.29%
PRGO price to sales ratio is higher than 22.29% of companies in Healthcare sector

Enterprise value

Enterprise Value

$6.78 B
PRGO enterprise value is $6.78 billion

Enterprise Value Sector Rank

89.71%
PRGO enterprise value is higher than 89.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.67
PRGO EV/EBITDA is 15.67

EV/EBITDA Sector Rank

87.39%
PRGO EV/EBITDA is higher than 87.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.38
PRGO annual current ratio is 2.38

Annual Quick Ratio

1.34
PRGO annual quick ratio is 1.34

Leverage

Annual Debt To Equity

0.84
PRGO annual debt to equity ratio is 0.84

Annual Interest Coverage Ratio

0.57
PRGO annual interest coverage ratio is 0.57

Risk & Stability

Piotroski F-Score

4
PRGO piotroski f-score is 4

Altman Z-Score

0.76
PRGO altman z-score is 0.76

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$9.65 B
PRGO annual total assets is $9.65 billion

Annual Non Current Assets

$7.17 B
PRGO annual long term assets is $7.17 billion

Annual Current Assets

$2.48 B
PRGO annual total current assets is $2.48 billion

Annual Cash & Cash Equivalents

$558.80 M
PRGO annual cash & cash equivalents is $558.80 million

Equity

Annual Book Value

$4.32 B
PRGO annual book value is $4.32 billion

Annual Working Capital

$1.44 B
PRGO annual working capital is $1.44 billion

Liabilities

Annual Total Liabilities

$5.33 B
PRGO annual total liabilities is $5.33 billion

Annual Total Long Term Liabilities

$4.28 B
PRGO annual total long term liabilities is $4.28 billion

Annual Current Liabilities

$1.04 B
PRGO annual total current liabilities is $1.04 billion

Annual Accounts Payable

$495.20 M
PRGO annual accounts payable is $495.20 million

Debt

Annual Total Debt

$3.62 B
PRGO annual total debt is $3.62 billion

Annual Total Debt 1-Year Change

-11.18%
PRGO annual total debt is down -11.18% year-on-year

Annual Long Term Debt

$3.58 B
PRGO annual long term debt is $3.58 billion

Annual Short Term Debt

$36.40 M
PRGO annual short term debt is $36.40 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.06 B
PRGO annual total expenses is $4.06 billion

Annual Operating Expenses

$1.23 B
PRGO annual total operating expenses is $1.23 billion

Annual Cost Of Goods Sold

$2.83 B
PRGO annual cost of goods sold is $2.83 billion

Annual SGA

$1.11 B
PRGO annual SGA is $1.11 billion

Annual D&A

$325.90 M
PRGO annual depreciation & amortization is $325.90 million

Annual Interest Expense

$187.80 M
PRGO annual interest expense is $187.80 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$362.90 M
PRGO annual cash flow from operations is $362.90 million

Annual CFO 1-Year Change

-10.51%
PRGO annual cash flow from operations is down -10.51% year-on-year

Annual CFI

$78.80 M
PRGO annual cash flow from investing activities is $78.80 million

Annual CFI 1-Year Change

+201.68%
PRGO annual cash flow from investing activities is up +201.68% year-on-year

Annual CFF

-$611.00 M
PRGO annual cash flow from financing activities is -$611.00 million

Annual CFF 1-Year Change

-226.39%
PRGO annual cash flow from financing activities is down -226.39% year-on-year

Free CashFlow

Annual FCF

$244.60 M
PRGO annual free cash flow is $244.60 million

Annual FCF 1-Year Change

-19.49%
PRGO annual free cash flow is down -19.49% year-on-year

CAPEX

Annual CAPEX

$118.30 M
PRGO annual capital expenditures is $118.30 million

Annual CAPEX 1-Year Change

+16.32%
PRGO annual capital expenditures is up +16.32% year-on-year

Institutional Ownership

Similar stocks

SWTX logo
SpringWorks Therapeutics (SWTX)
RDNT logo
RadNet (RDNT)
RNA logo
Avidity Biosciences (RNA)
ACLX logo
Arcellx (ACLX)
CRSP logo
CRISPR Therapeutics AG (CRSP)
RARE logo
Ultragenyx Pharmaceutical (RARE)
ZLAB logo
Zai Lab Limited (ZLAB)
ADMA logo
ADMA Biologics (ADMA)
ICUI logo
ICU Medical (ICUI)

FAQ

  • What is the ticker symbol for Perrigo?
  • Does Perrigo pay dividends?
  • What sector is Perrigo in?
  • What industry is Perrigo in?
  • What country is Perrigo based in?
  • When did Perrigo go public?
  • Is Perrigo in the S&P 500?
  • Is Perrigo in the NASDAQ 100?
  • Is Perrigo in the Dow Jones?
  • When was Perrigo's last earnings report?
  • When does Perrigo report earnings?
  • Should I buy Perrigo stock now?

What is the ticker symbol for Perrigo?

The ticker symbol for Perrigo is NYSE:PRGO

Does Perrigo pay dividends?

Yes, Perrigo pays dividends. The last payment was $0.29, with an ex-dividend date on March 7, 2025

What sector is Perrigo in?

Perrigo is in the Healthcare sector

What industry is Perrigo in?

Perrigo is in the Drug Manufacturers - Specialty & Generic industry

What country is Perrigo based in?

Perrigo is headquartered in Ireland

When did Perrigo go public?

Perrigo's initial public offering (IPO) was on December 17, 1991

Is Perrigo in the S&P 500?

No, Perrigo is not included in the S&P 500 index

Is Perrigo in the NASDAQ 100?

No, Perrigo is not included in the NASDAQ 100 index

Is Perrigo in the Dow Jones?

No, Perrigo is not included in the Dow Jones index

When was Perrigo's last earnings report?

Perrigo's most recent earnings report was on Feb 27, 2025

When does Perrigo report earnings?

The next expected earnings date for Perrigo is May 7, 2025

Should I buy Perrigo stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions